logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Skin Diseases

    FiltersReset Filters
    34 results

    • analpram hc

      (hydrocortisone acetate and pramoxine hydrochloride)
      Sebela Pharmaceuticals Inc.
      Usage: Topical corticosteroids are indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.

    • betamethasone dipropionate

      (Betamethasone Dipropionate)
      Taro Pharmaceuticals U.S.A., Inc.
      Usage: Betamethasone dipropionate cream is a medium-potency corticosteroid indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions in patients aged 13 and older.

    • betamethasone dipropionate

      (betamethasone dipropionate)
      E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
      Usage: Betamethasone dipropionate ointment (augmented), 0.05% is indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions in individuals aged 13 and older.

    • betamethasone valerate

      (Betamethasone Valerate Foam)
      Xiromed, LLC.
      Usage: Betamethasone valerate foam, 0.12%, is indicated for the relief of inflammatory and itching symptoms associated with corticosteroid-responsive skin conditions of the scalp.

    • clobetasol propionate

      (CLOBETASOL PROPIONATE)
      Aurobindo Pharma Limited
      Usage: Clobetasol propionate ointment is indicated for relieving inflammation and itching in corticosteroid-responsive skin conditions. Treatment should not exceed 2 weeks or 50 g/week due to potential HPA axis suppression. It is not recommended for use in patients under 12 years old. Reassess if no improvement occurs in 2 weeks.

    • clobetasol propionate

      (clobetasol propionate)
      Lupin Pharmaceuticals Inc
      Usage: Clobetasol propionate topical solution is indicated for short-term treatment of inflammatory and itchy skin conditions responsive to corticosteroids on the scalp. Treatment should not exceed two consecutive weeks or 50 mL/week due to potential HPA axis suppression. Not recommended for patients under 12 years.

    • clobetasol propionate

      (CLOBETASOL PROPIONATE)
      Alembic Pharmaceuticals Inc.
      Usage: Clobetasol Propionate Topical Solution USP, 0.05% is indicated for short-term treatment of inflammatory and itchy skin conditions on the scalp that respond to corticosteroids. Use is limited to 2 weeks and a maximum of 50 mL/week due to potential HPA axis suppression. Not for patients under 12 years old.

    • clobetasol propionate

      (CLOBETASOL PROPIONATE)
      Alembic Pharmaceuticals Limited
      Usage: Clobetasol propionate cream is indicated for relieving inflammatory and pruritic symptoms of corticosteroid-responsive skin conditions. Use is limited to 2 weeks and should not exceed 50 g/week to avoid HPA axis suppression. Not recommended for children under 12; reevaluate if no improvement occurs within 2 weeks.

    • clobetasol propionate

      (Clobetasol Propionate)
      Macleods Pharmaceuticals Limited
      Usage: Clobetasol propionate ointment is indicated for relief of inflammatory and pruritic symptoms from corticosteroid-responsive skin conditions. Treatment should not exceed two weeks or 50 g/week. Not recommended for children under 12. Discontinue once control is achieved; reassess if no improvement occurs within two weeks.

    • clobetasol propionate

      (Clobetasol Propionate)
      Macleods Pharmaceuticals Limited
      Usage: Clobetasol propionate topical solution is indicated for short-term treatment of inflammatory and pruritic conditions of the scalp caused by moderate to severe corticosteroid-responsive dermatoses. Use should not exceed 2 weeks or 50 mL/week, and it's not recommended for patients under 12 years old.